We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.49B
Cap. Flow %
8.21%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 14.21%
3 Consumer Discretionary 12.36%
4 Industrials 10.91%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLP
1776
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
-42,920
Closed -$601K
BUFF
1777
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
-126,293
Closed -$3.54M
CSRA
1778
DELISTED
CSRA Inc.
CSRA
-275,018
Closed -$8.8M
CASC
1779
DELISTED
Cascadian Therapeutics, Inc.
CASC
-13,443
Closed -$54K
CCC
1780
DELISTED
Calgon Carbon Corp
CCC
-325,476
Closed -$6.83M
JUNO
1781
DELISTED
Juno Therapeutics, Inc.
JUNO
-36,009
Closed -$1.62M
CAA
1782
DELISTED
CalAtlantic Group, Inc.
CAA
-17,858
Closed -$661K
SCMP
1783
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
-29,773
Closed -$357K
BKMU
1784
DELISTED
Bank Mutual Corp
BKMU
-33,869
Closed -$339K
IXYS
1785
DELISTED
IXYS Corp
IXYS
-39,643
Closed -$951K
SSNI
1786
DELISTED
Silver Spring Networks, Inc.
SSNI
-16,083
Closed -$257K
FIG
1787
DELISTED
Fortress Investment Group Llc
FIG
-391,724
Closed -$3.13M
OME
1788
DELISTED
Omega Protein
OME
-29,808
Closed -$507K
TESO
1789
DELISTED
Tesco Corp
TESO
-136,892
Closed -$684K
PMC
1790
DELISTED
PharMerica Corporation
PMC
-194,979
Closed -$5.65M
RIC
1791
DELISTED
Richmont Mines Inc.
RIC
-13,590
Closed -$122K
VWR
1792
DELISTED
VWR Corporation
VWR
-593,367
Closed -$19.6M
BRCD
1793
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
-178,064
Closed -$2.14M
RATE
1794
DELISTED
Bankrate Inc
RATE
-20,982
Closed -$294K
WNRL
1795
DELISTED
Western Refining Logistics, LP
WNRL
-37,923
Closed -$986K
CUNB
1796
DELISTED
CU Bancorp
CUNB
-75,757
Closed -$2.96M
LDR
1797
DELISTED
Landauer Inc
LDR
-71,653
Closed -$4.8M
SCLN
1798
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
-843,451
Closed -$9.28M
PKY
1799
DELISTED
Parkway, Inc.
PKY
-253,516
Closed -$5.83M
CACQ
1800
DELISTED
Caesars Acquisition Company
CACQ
-10,284
Closed -$216K

Similar funds

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.